BioSpace News Archive

DiNAQOR, a genetic medicine platform company focused on addressing severe inherited cardiac diseases, today announced it has entered into a research collaboration with Children’s Medical Research Institute (CMRI) in Australia to develop novel bioengineered adeno-associated virus (AAV) capsids to route gene therapy directly to human cardiac muscle.

Wolters Kluwer, Health today announced the launch of Ovid® Synthesis, a new suite of applications to power highly effective evidence-based workflows in the healthcare setting that complement Ovid’s premium medical content.

According to Emergen Research, the global cardiac monitoring & cardiac rhythm management devices market size was USD 22.64 billion in 2020 and is expected to reach USD 30.52 billion in 2028 and register a revenue CAGR of 4.1% during the forecast period, 2021-2028.

According to Emergen Research, the global healthcare Internet of Things (IoT) market size was USD 1.15 Billion in 2020 and is expected to reach USD 5.52 Billion in 2028 and register a revenue CAGR of 21.6% during the forecast period, 2021-2028.

According to Emergen Research, the global nanopharmaceutical drugs market size was USD 50.32 billion in 2020 and is expected to reach USD 88.74 billion in 2028 and register a revenue CAGR of 7.3% during the forecast period, 2021-2028.

According to Emergen Research, the global in silico drug discovery market size was USD 2.68 billion in 2020 and is expected to reach USD 7.16 billion in 2028 and register a revenue CAGR of 13.0% during the forecast period, 2021-2028.

We’ve long been captivated by cloud, Internet of Things (IoT), artificial intelligence (AI), machine learning (ML), and blockchain technologies in the IT sector, but a lot has happened in the previous eighteen months as the world battled the pandemic.

Increasing prevalence of various chronic diseases and rising demand for remote patient monitoring due to high elderly population are key factors driving global market revenue growth.

Aardvark Therapeutics, Inc. proudly announces that it has received an invitation to present at the 40th annual J.P. Morgan Healthcare Conference on January 13th, 2022.

Immune-Onc Therapeutics, Inc. today announced the Company will present at the virtual 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022, at 12:30 PM PST/3:30 PM EST.